Health Condition 1: I11- Hypertensive heart disease Health Condition 2: I20-I25- Ischemic heart diseases Health Condition 3: I30-I52- Other forms of heart disease Health Condition 4: I089- Rheumatic multiple valve disease,unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
SMS Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Participants diagnosed with cardiac disability as per CDS-HDC classification categories A, B, or C (Mishra et al) will be included. Group A: Heart diseases with mild or no hemodynamic abnormalities and low risk of progression such as small patent foramen ovale, small atrial septal defect, small patent ductus arteriosus, mild pulmonary stenosis, bicuspid aortic valve with mild regurgitation, Ebstein anomaly grade I or II, or repaired congenital heart disease without residual dysfunction. Heart diseases improved by palliative procedures such as mild hypertrophic cardiomyopathy, viral myocarditis, rheumatic heart disease, Kawasaki disease, or mild stenotic lesions are also included. Controlled systemic or pulmonary hypertension and mild arrhythmias such as Wolff-Parkinson-White syndrome are eligible. Group B: Heart diseases with significant hemodynamic effects and moderate risk of progression such as pre- or post-tricuspid shunts, coronary arteriovenous fistula, Ebstein anomaly with moderate tricuspid regurgitation, congenital or degenerative valvular diseases, hypertrophic or dilated cardiomyopathy, coronary artery disease, and Marfan syndrome. Patients with residual lesions after corrective surgery such as repaired tetralogy of Fallot, transposition of great arteries, coarctation of aorta, or valvar disease are included. Heart diseases partially improved by palliation such as systemic to pulmonary artery shunt, pulmonary artery banding, or Senning or arterial switch palliation are also eligible. Moderate systemic or pulmonary hypertension and significant arrhythmias such as complete heart block, long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia are included. Group C: Heart diseases with severe hemodynamic abnormalities or those requiring intervention such as large shunts, Eisenmenger syndrome, severe obstructive or regurgitant lesions, complex cyanotic congenital heart diseases, advanced cardiomyopathies, severe valvular diseases, or significant coronary artery disease. Patients with persistent dysfunction, desaturation, arrhythmia, or hypertension after corrective surgery are included. Palliated heart diseases with ongoing dysfunction such as Fontan or total cavopulmonary connection complications, persistent cyanosis, or severe pulmonary hypertension are also included. Severe systemic or pulmonary hypertension with end-organ dysfunction and life-threatening arrhythmias such as ICD-dependent arrhythmias, arrhythmogenic right ventricular dysplasia, or intractable tachyarrhythmias are also eligible.
Exclusion criteria
Exclusion criteria: Patients will be excluded if they have primary non-cardiac disabilities affecting daily functioning such as neurological, orthopedic, respiratory, or systemic causes unrelated to heart disease. Patients unwilling or unable to provide informed consent will be excluded. Patients unable to understand or respond reliably to the questionnaire, including those with severe cognitive impairment, language barriers, or illiteracy without caregiver support, will not be included. Patients who have undergone major cardiac surgery or intervention such as bypass grafting, valve replacement, device closure, or stenting within the last twelve months will be excluded. Patients with unstable hemodynamics, acute cardiac decompensation, or ongoing emergency cardiac procedures at the time of screening will not be eligible. Patients with severe psychiatric illness interfering with study participation or those currently enrolled in another interventional clinical trial will also be excluded. The principal investigator may exclude any participant considered unsuitable for safe and reliable participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantify the occurrence of cardiac disability using the Global Disability Scale in a large tertiary care center in India.Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess the socioeconomic & demographic correlates of different levels of cardiac disabilityTimepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactAishwarya Vyas
SMS Medical College, Jaipur
Outcome results
None listed